Richard Peterson
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
Richard D.
Peterson is currently an Independent Director at Universal Insurance Holdings, Inc. since 2014, a Member of The Financial Executives Institute, and Chief Financial Officer at Turn Biotechnologies, Inc. since 2022.
Formerly, Mr. Peterson was Director at The Arizona Center For Nature Conservation; Chief Financial Officer, Treasurer & Executive Vice President at Medicis Pharmaceutical Corp.
from 2011 to 2012; Senior Financial Auditor at PricewaterhouseCoopers LLP from 1992 to 1995; Chief Financial Officer at Clarus Therapeutics, Inc.; CFO & Principal Accounting Officer at NVN Liquidation, Inc. from 2015 to 2017; Chief Financial Officer at Botanix Pharmaceuticals Ltd. from 2019 to 2020; Chief Financial & Accounting Officer at Sienna Biopharmaceuticals, Inc. from 2017 to 2018; Chief Financial Officer at Dermavant Sciences, Inc. from 2018 to 2019; and Chief Financial Officer at Clarus Therapeutics Holdings, Inc. from 2021 to 2022.
Education includes an undergraduate degree from Arizona State University conferred in 1992.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-06-2026 | 28.869 ( 0,1% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Directeur/Bestuurslid | 05-06-2014 |
The Financial Executives Institute | Corporate Officer/Principal | 26-05-2009 |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Financieel Directeur/CFO | 01-09-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Financieel Directeur/CFO | 31-08-2022 |
| BOTANIX PHARMACEUTICALS LIMITED | Financieel Directeur/CFO | 01-05-2020 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Financieel Directeur/CFO | 01-02-2019 |
| SIENNA BIOPHARMACEUTICALS, INC. | Financieel Directeur/CFO | 29-03-2018 |
| NVN LIQUIDATION, INC. | Financieel Directeur/CFO | 23-03-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 13 |
|---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Universal Insurance Holdings, Inc.
Universal Insurance Holdings, Inc. Property/Casualty InsuranceFinance Operates as a holding company whose subsidiaries provides property and casualty insurance services | Finance |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
NVN Liquidation, Inc.
NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
Botanix Pharmaceuticals Ltd.
Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Financial Executives Institute | |
The Arizona Center For Nature Conservation
The Arizona Center For Nature Conservation Other Consumer ServicesConsumer Services Operates as a zoo that provides conservatory of animals and habitats | Consumer Services |
Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau